|
Quote |
Price | |
$50.50 |
|
Price change for today in $ | |
0.00 |
|
Price change for today in % | |
0.00 |
|
Open Price | |
$0.00 |
|
Previous Close | |
$50.50 |
|
Daily Range | |
$0.00 - $0.00 |
|
52-Week Range | |
$25.64 - $53.99 |
|
Volume | |
0 |
|
| |
 |
| |
Brokerage Analyst Recommendations
|
| 16 Brokerage Firms Covering SLXP |
| |
|
Strong Buy
11 |
Buy
0 |
Hold
5 |
Sell
0 |
Strong Sell
0 |
|
| Average Broker Recommendation (ABR):1.63 |
| |
|
| Description |
| Salix Pharmaceuticals, Ltd. objective is to be a market-driven specialtypharmaceutical company focussed on the needs of physicians specializing ingastroenterology. The company intends to establish a small direct sales force to promote its products to this specialist audience. The company's strategy is to identify and acquire products that have near-term commercial potential and apply its regulatory and product development expertise to commercialize these products. The company selects products that it believes serve a gastrointestinal disease. |
| |
8510 COLONNADE CENTER DRIVE
RALEIGH, NC
27615, USA
Phone: (919) 862-1000
Fax: 919-862-1095
Web: http://www.salix.com/
Email: nvestor.relations@salix.com |
Industry:MED-DRUGS
Sector: Medical
Fiscal Year End:December
Last Reported Quarter:03/31/12
Next EPS Date:08/06/12 |
|
|
